Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis

The number of patients with chronic kidney disease is increasing globally. For patients with end-stage kidney disease, hemodialysis (HD) is the most common kidney replacement therapy. Among the currently common types of clinical vascular access, arteriovenous fistula (AVF) is the most widely used di...

Full description

Saved in:
Bibliographic Details
Main Authors: Ma Shi-jie, Deng Fei
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2025-07-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.07.012
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850066802589040640
author Ma Shi-jie
Deng Fei
author_facet Ma Shi-jie
Deng Fei
author_sort Ma Shi-jie
collection DOAJ
description The number of patients with chronic kidney disease is increasing globally. For patients with end-stage kidney disease, hemodialysis (HD) is the most common kidney replacement therapy. Among the currently common types of clinical vascular access, arteriovenous fistula (AVF) is the most widely used dialysis vascular access worldwide. However, arteriovenous fistula often leads to access dysfunction due to thrombosis. Antiplatelet drugs, due to their positive effect on inhibiting thrombosis, are considered as potential therapeutics to prevent arteriovenous fistula thrombosis. This article reviewed the application of antiplatelet drugs in the treatment of arteriovenous fistula in HD patients.
format Article
id doaj-art-c0f3bed7b85746098aebaecaa14a82b2
institution DOAJ
issn 1671-2390
language zho
publishDate 2025-07-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-c0f3bed7b85746098aebaecaa14a82b22025-08-20T02:48:38ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902025-07-0125617621117476267Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysisMa Shi-jieDeng FeiThe number of patients with chronic kidney disease is increasing globally. For patients with end-stage kidney disease, hemodialysis (HD) is the most common kidney replacement therapy. Among the currently common types of clinical vascular access, arteriovenous fistula (AVF) is the most widely used dialysis vascular access worldwide. However, arteriovenous fistula often leads to access dysfunction due to thrombosis. Antiplatelet drugs, due to their positive effect on inhibiting thrombosis, are considered as potential therapeutics to prevent arteriovenous fistula thrombosis. This article reviewed the application of antiplatelet drugs in the treatment of arteriovenous fistula in HD patients.http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.07.012HemodialysisArteriovenous fistulaAntiplatelet drug
spellingShingle Ma Shi-jie
Deng Fei
Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
Linchuang shenzangbing zazhi
Hemodialysis
Arteriovenous fistula
Antiplatelet drug
title Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
title_full Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
title_fullStr Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
title_full_unstemmed Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
title_short Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
title_sort research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
topic Hemodialysis
Arteriovenous fistula
Antiplatelet drug
url http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.07.012
work_keys_str_mv AT mashijie researchprogressontheapplicationofantiplateletdrugsinarteriovenousfistulaforhemodialysis
AT dengfei researchprogressontheapplicationofantiplateletdrugsinarteriovenousfistulaforhemodialysis